Role of mucins in the skin during benign and malignant conditions

Subhankar Chakraborty, Neelima Bonthu, Benjamin J Swanson, Surinder Kumar Batra

Research output: Contribution to journalShort survey

20 Citations (Scopus)

Abstract

Skin-related diseases comprise a major health challenge to the practicing physician, and constitute a significant psychological, social and financial burden to the society. Further, skin cancer, especially non-melanoma skin cancer is currently the leading type of malignancy in the Western world. Given the huge burden of skin diseases, there is growing emphasis on understanding their pathophysiology, and towards their early detection. Mucins are high-molecular weight O- and N-linked glycoproteins that have emerged in recent years as important molecules in maintaining health and in promoting or protecting against inflammation and cancer. They have also begun to emerge as highly specific diagnostic and prognostic markers and novel therapeutic targets in several malignant disorders. However, their role in cutaneous pathologies has remained largely obscured. The present review provides the expression patterns and proposed role of mucins in the healthy skin and various benign and malignant skin diseases. The review has immense clinical significance as the availability of highly specific reagents including monoclonal antibodies against mucins makes them extremely attractive targets for specific diagnosis and/or immunotherapy of benign and malignant cutaneous diseases.

Original languageEnglish (US)
Pages (from-to)127-141
Number of pages15
JournalCancer Letters
Volume301
Issue number2
DOIs
StatePublished - Feb 28 2011

Fingerprint

Mucins
Skin Diseases
Skin
Skin Neoplasms
Western World
Health
Immunotherapy
Neoplasms
Glycoproteins
Molecular Weight
Monoclonal Antibodies
Pathology
Psychology
Inflammation
Physicians
Therapeutics

Keywords

  • Cutaneous diseases
  • Diagnosis
  • Mucin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Role of mucins in the skin during benign and malignant conditions. / Chakraborty, Subhankar; Bonthu, Neelima; Swanson, Benjamin J; Batra, Surinder Kumar.

In: Cancer Letters, Vol. 301, No. 2, 28.02.2011, p. 127-141.

Research output: Contribution to journalShort survey

Chakraborty, Subhankar ; Bonthu, Neelima ; Swanson, Benjamin J ; Batra, Surinder Kumar. / Role of mucins in the skin during benign and malignant conditions. In: Cancer Letters. 2011 ; Vol. 301, No. 2. pp. 127-141.
@article{e53aa8c81b7440fe81470c780d6ff530,
title = "Role of mucins in the skin during benign and malignant conditions",
abstract = "Skin-related diseases comprise a major health challenge to the practicing physician, and constitute a significant psychological, social and financial burden to the society. Further, skin cancer, especially non-melanoma skin cancer is currently the leading type of malignancy in the Western world. Given the huge burden of skin diseases, there is growing emphasis on understanding their pathophysiology, and towards their early detection. Mucins are high-molecular weight O- and N-linked glycoproteins that have emerged in recent years as important molecules in maintaining health and in promoting or protecting against inflammation and cancer. They have also begun to emerge as highly specific diagnostic and prognostic markers and novel therapeutic targets in several malignant disorders. However, their role in cutaneous pathologies has remained largely obscured. The present review provides the expression patterns and proposed role of mucins in the healthy skin and various benign and malignant skin diseases. The review has immense clinical significance as the availability of highly specific reagents including monoclonal antibodies against mucins makes them extremely attractive targets for specific diagnosis and/or immunotherapy of benign and malignant cutaneous diseases.",
keywords = "Cutaneous diseases, Diagnosis, Mucin",
author = "Subhankar Chakraborty and Neelima Bonthu and Swanson, {Benjamin J} and Batra, {Surinder Kumar}",
year = "2011",
month = "2",
day = "28",
doi = "10.1016/j.canlet.2010.11.004",
language = "English (US)",
volume = "301",
pages = "127--141",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Role of mucins in the skin during benign and malignant conditions

AU - Chakraborty, Subhankar

AU - Bonthu, Neelima

AU - Swanson, Benjamin J

AU - Batra, Surinder Kumar

PY - 2011/2/28

Y1 - 2011/2/28

N2 - Skin-related diseases comprise a major health challenge to the practicing physician, and constitute a significant psychological, social and financial burden to the society. Further, skin cancer, especially non-melanoma skin cancer is currently the leading type of malignancy in the Western world. Given the huge burden of skin diseases, there is growing emphasis on understanding their pathophysiology, and towards their early detection. Mucins are high-molecular weight O- and N-linked glycoproteins that have emerged in recent years as important molecules in maintaining health and in promoting or protecting against inflammation and cancer. They have also begun to emerge as highly specific diagnostic and prognostic markers and novel therapeutic targets in several malignant disorders. However, their role in cutaneous pathologies has remained largely obscured. The present review provides the expression patterns and proposed role of mucins in the healthy skin and various benign and malignant skin diseases. The review has immense clinical significance as the availability of highly specific reagents including monoclonal antibodies against mucins makes them extremely attractive targets for specific diagnosis and/or immunotherapy of benign and malignant cutaneous diseases.

AB - Skin-related diseases comprise a major health challenge to the practicing physician, and constitute a significant psychological, social and financial burden to the society. Further, skin cancer, especially non-melanoma skin cancer is currently the leading type of malignancy in the Western world. Given the huge burden of skin diseases, there is growing emphasis on understanding their pathophysiology, and towards their early detection. Mucins are high-molecular weight O- and N-linked glycoproteins that have emerged in recent years as important molecules in maintaining health and in promoting or protecting against inflammation and cancer. They have also begun to emerge as highly specific diagnostic and prognostic markers and novel therapeutic targets in several malignant disorders. However, their role in cutaneous pathologies has remained largely obscured. The present review provides the expression patterns and proposed role of mucins in the healthy skin and various benign and malignant skin diseases. The review has immense clinical significance as the availability of highly specific reagents including monoclonal antibodies against mucins makes them extremely attractive targets for specific diagnosis and/or immunotherapy of benign and malignant cutaneous diseases.

KW - Cutaneous diseases

KW - Diagnosis

KW - Mucin

UR - http://www.scopus.com/inward/record.url?scp=78651460237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651460237&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2010.11.004

DO - 10.1016/j.canlet.2010.11.004

M3 - Short survey

VL - 301

SP - 127

EP - 141

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -